Giant Eagle Pharmacy #0040 is an authorized DME supplier for medicare equipments and products.
Giant Eagle Pharmacy #0040 is a Community/Retail Pharmacy in Pittsburgh, Pennsylvania. This pharmacy is owned and operated by Giant Eagle Inc. It is located at 5550 Centre Ave, Pittsburgh and it's customer support contact number is 412-682-5466. The authorized person of Giant Eagle Pharmacy #0040 is Debra Krasnow who is Director Managed Care of the pharmacy and his contact number is 412-968-1550. Active license number of Giant Eagle Pharmacy #0040 is PP481115 for Community/Retail Pharmacy in Pennsylvania. Giant Eagle Pharmacy #0040 accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Giant Eagle Pharmacy #0040 is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Giant Eagle Pharmacy #0040 type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Giant Eagle Pharmacy #0040
Type:
Community/Retail Pharmacy
Location:
5550 Centre Ave, Pittsburgh, Pennsylvania, 15232-1206
Phone:
412-682-5466
Fax:
412-682-5728
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Debra Krasnow
Position:
Director Managed Care
Contact Number:
412-968-1550
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1861407793
NPI Enumeration Date:
29 Jul, 2006
NPI Last Update On:
18 Jun, 2015
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Giant Eagle Pharmacy #0040 are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
PP481115
Pennsylvania
Primary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
1007285680212
Medicaid
Pennsylvania
3981013
Other
Other Id Number-commercial Number
870021414
Other
Pennsylvania
Medicare Railroad Flu Giant Eagle Pa
Medicare Enrollment:
Giant Eagle Pharmacy #0040 is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
8921083049
O20100930032267
Giant Eagle Inc
DME SUPPLIER - PHARMACY
Products Available:
Giant Eagle Pharmacy #0040 has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Mail Order
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Nebulizer Equipment & Supplies
Ostomy Supplies
Surgical Dressings
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
101 Kappa Dr, Pittsburgh, Pennsylvania
Zip:
15238-2809
Phone Number:
--
Fax Number:
--
Patients can reach Giant Eagle Pharmacy #0040 at 5550 Centre Ave, Pittsburgh, Pennsylvania or can call on customer care at 412-682-5466.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.